{"url":"https://lda.senate.gov/api/v1/filings/620671db-86f2-4fbb-a35f-e3dd17f7ffe0/","filing_uuid":"620671db-86f2-4fbb-a35f-e3dd17f7ffe0","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2009,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/620671db-86f2-4fbb-a35f-e3dd17f7ffe0/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David F. Taylor Jr, CEO","dt_posted":"2009-04-20T10:31:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1737 H STREET, NW","registrant_address_2":"SUITE 200","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":47108,"url":"https://lda.senate.gov/api/v1/registrants/47108/","house_registrant_id":34430,"name":"CAPITOL SOLUTIONS","description":"Government Relations Consultants","address_1":"1800 Diagonal Road","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID TAYLOR","contact_telephone":"+1 703-647-7537","dt_updated":"2022-04-06T16:08:08.464604-04:00"},"client":{"id":154449,"url":"https://lda.senate.gov/api/v1/clients/154449/","client_id":1002842,"name":"AMGEN USA","general_description":"Biotechnology Company","client_government_entity":false,"client_self_select":false,"state":null,"state_display":null,"country":"","country_display":"* Undetermined","ppb_state":null,"ppb_state_display":null,"ppb_country":"","ppb_country_display":"* Undetermined","effective_date":"2007-07-23"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to State Children's Health Insurance Program (SCHIP)\nH.R. 1, The American Recovery and Reinvestment Act of 2009; Issues related to medicare proportionality\nH.R. 5629, To establish a pathway for licensure of biosimilars biological products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40648,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"C","last_name":"TATE","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}